Daily Stock List
Inspyr Therapeutics, Inc. (NSPX)
BUYINS.NET reported earlier on Inspyr Therapeutics, Inc. (NSPX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Inspyr Therapeutics, Inc. is a clinical-stage biotechnology company listed on the OTCQB. It is developing novel prodrug therapeutics for the treatment of cancer. Mipsagargin is the Company’s lead agent. It is in human clinical trials for patients with a number of different tumor types. Inspyr Therapeutics’ team has considerable pharmaceutical industry and scientific experience. The Company is based in Westlake Village, California.
Inspyr Therapeutics is developing a novel technology platform. It combines a powerful therapeutic (thapsigargin) with a patented prodrug delivery system, which targets the release of drugs within solid tumors without the side effects of chemotherapeutic agents. The innovative platform technology has the potential to work across a spectrum of drugs that precisely target different cancers.
Mipsagargin (G-202) is a prodrug in human clinical trials for patients with hepatocellular carcinoma (HCC, or liver cancer), glioblastoma (GBM, or brain cancer) and prostate cancer. Mipsagargin has been studied in a Phase 2 clinical trial in patients with hepatocellular carcinoma (liver cancer) and has been granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in this indication.
Currently, Mipsagargin is undergoing evaluation in an open-label, single-arm, Phase II clinical study in patients with glioblastoma (brain cancer). In addition, it is undergoing evaluation in two Phase II clinical pilot studies in patients with prostate and clear cell renal cancer.
Yesterday, Inspyr Therapeutics announced the initiation of the second development program for Mipsagargin as part of a combination therapeutic approach. This new program is centered on the treatment of gastric cancer. Inspyr has started a preclinical study in gastric cancer PDX tumor models that express varying levels of PSMA, the target of Mipsagargin. In this initial study, Mipsagargin will undergo evaluation initially in combination with paclitaxel.
Inspyr also plans to evaluate Mipsagargin in combination with DC101 (Cyramza® surrogate antibody). Paclitaxel and Cyramza® are approved for the treatment of gastric cancer. Inspyr Therapeutics expects to share initial results from this initial study in the second half of this year.
Inspyr Therapeutics, Inc. (NSPX), closed Thursday's trading session at $0.55, even for the day, on 20,405 volume with 3 trades. The average volume for the last 60 days is 1,300 and the stock's 52-week low/high is $0.355/$5.01.
Intrusion, Inc. (INTZ)
Marketbeat, OTC Markets Group, Penny Omega, and OTC Picks reported earlier on Intrusion, Inc. (INTZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Intrusion, Inc. is a global provider of entity identification, high speed data mining, cybercrime, and advanced persistent threat detection products. The Company has a long record of accomplishment of delivering proven, strong, network monitoring and analysis solutions to high profile customers. These include Fortune 500 financial services companies and also the U.S. government. Intrusion has its headquarters in Richardson, Texas and the Company lists on the OTC Markets’ OTCQB.
Intrusion’s products help protect critical information assets through rapidly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks. The Company’s product families include TraceCop™ for identity discovery and disclosure, Savant™ for network data mining and advanced persistent threat detection.
TraceCop™ is a set of Internet monitoring and tracking products. TraceCop™ provides exceptional capabilities for the identification of malicious and illegal activities based on historical and current Internet usage data.
In addition, Intrusion’s Savant™ is a transparent network data capture and analysis solution. It brings science into corporate decision making.
Intrusion has its Secure Taps™ - Network Taps Products. It offers a collection of secure network taps that enable easy, fast, and strong deployment of any of the Company’s network security appliances.
This week, Intrusion announced financial results for the quarter and year ended December 31, 2016. The Company’s net loss for Q4 2016 was $0.3 million, versus a net loss of $0.5 million for Q4 2015. Net loss for the year 2016 was $1.6 million, versus a net loss of $1.2 million for 2015.
Revenue for Q4 2016 was $1.4 million, versus $1.5 million in Q4 2015. Revenue for the year 2016 was $6.1 million, versus $6.8 million in 2015. Gross profit margin rose to 65 percent of revenue in Q4 of 2016, versus 63 percent of revenue in Q4 2015. For the year, the gross profit margin rose to 64 percent, versus 63 percent in 2015.
Intrusion, Inc. (INTZ), closed Thursday's trading session at $0.33891, up 42.40%, on 10,870 volume with 4 trades. The average volume for the last 60 days is 10,945 and the stock's 52-week low/high is $0.12/$0.9997.
Energy Services of America Corp. (ESOA)
Marketbeat and Real Pennies reported earlier on Energy Services of America Corp. (ESOA), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Energy Services of America Corp. provides contracting services for energy related companies. At present, it principally serves the gas, petroleum, power, chemical, and automotive industries. However, the Company does some other incidental work such as water and sewer projects. Energy Services of America is the parent company of C.J. Hughes Construction Company and Nitro Electric Company. Energy Services of America is based in Huntington, West Virginia. Its shares trade on the OTCQB
The majority of the Company’s customers are in West Virginia, Virginia, Ohio, Pennsylvania, and Kentucky. Regarding the oil industry, Energy Services of America provides a variety of services relating to pipeline, storage facilities, as well as plant work.
For the power, chemical, and automotive industries, it provides a complete range of electrical and mechanical installations and repairs. This includes substation and switchyard services, site preparation, equipment setting, pipe fabrication and installation, packaged buildings, transformers and other ancillary work with regards to these.
Concerning the gas industry, Energy Services of America primarily engages in the construction, replacement and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It engages in the construction of interstate and intrastate pipelines, with a concentration on intrastate pipelines.
The Company’s other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, varied maintenance and repair services and other services related to pipeline construction.
Energy Services of America builds, but does not own, natural gas pipelines for its customers, which are part of interstate and intrastate pipeline systems that move natural gas from producing areas to consumption areas as well as constructing and replacing gas line services to individual customers of the different utility companies.
This month, Energy Services of America announced the filing of its quarterly report on Form 10-Q for the quarter ended December 31, 2016. The Company earned revenues of $37.5 million for the three months ended December 31, 2016. Gross profit and net income available to common shareholders were $4.7 million and $1.2 million, respectively, for the three months ended December 31, 2016.
Energy Services had adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) of $3.2 million ($0.22 per share) for the three months ended December 31, 2016. The Company’s backlog at December 31, 2016 was $81.2 million.
Energy Services of America Corp. (ESOA), closed Thursday's trading session at $1.69, up 4.32%, on 23,277 volume with 40 trades. The average volume for the last 60 days is 25,058 and the stock's 52-week low/high is $1.25/$1.92.
Provectus Biopharmaceuticals, Inc. (PVCT)
Stock News Now, Seeking Alpha, TopPennyStockMovers, StreetInsider, The Street, TopStockAnalysts, StreetAuthorityDaily, TheMicrocapNews, Streetwise Reports, AllPennyStocks, plrinvest, Investors Underground, Real Pennies, PennyStocks24, Club Penny Stocks Network, and Wise Alerts reported earlier on Provectus Biopharmaceuticals, Inc. (PVCT), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Provectus Biopharmaceuticals, Inc. is a clinical-stage oncology and dermatology biopharmaceutical company. It is developing new therapies for the treatment of solid tumor cancers and dermatologic diseases. The Company’s investigational oncology drug is PV-10. PV-10 is an oncolytic immunotherapy presently enrolling patients in Phase 3 clinical trials for metastatic melanoma. Provectus Biopharmaceuticals has its corporate headquarters in Knoxville, Tennessee.
The Company’s PV-10 is an ablative immunotherapy under investigation in solid tumor cancers. Provectus has received orphan drug designations from the Food and Drug Administration (FDA) for its melanoma and hepatocellular carcinoma indications.
Provectus’ PH-10 is a topical investigational drug for dermatology. PH-10 is undergoing clinical testing for psoriasis and atopic dermatitis. Provectus Pharmaceuticals completed Phase 2 trials of PV-10 as a therapy for metastatic melanoma, and of PH-10 as a topical treatment for atopic dermatitis and psoriasis.
PV-10 is a 10 percent solution of small molecule and halogenated xanthene Rose Bengal. It is administered through direct injection into solid tumor cancers, such as melanoma, liver, and breast. It is not designed to rely on a single pathway, receptor or antigen to work; and there is no known resistance. The intention of PV-10 is to kill only diseased cells upon injection into tumors. Proper cell death would be the subsequent upstream trigger for a systemic anti-tumor response.
The injection of Rose Bengal results in necrosis of tumor cells and the release of High Mobility Group Box 1 (HMGB1), with increased dendritic cell infiltration into draining lymph nodes and the activation of tumor-specific T cells. Rose Bengal is best classified
as a small molecule, though a very heavy one.
Concerning PH-10 for psoriasis and atopic dermatitis, a mechanism of action study is underway to measure the clinical and cellular response to PH-10's active investigational agent. A total of 226 subjects have been treated with PH-10 in Phase 1 or Phase 2 Clinical Trials.
Today, Provectus Biopharmaceuticals announced that it appointed Mr. Bruce Horowitz and Mr. Dominic Rodrigues as special advisers to the Company's Board of Directors. Mr. Horowitz and Mr. Rodrigues will advise the Board on financial and corporate strategy.
In addition, the Company announced that it received an investment commitment of up to $2.5 million from Eric Wachter, Ph.D., Co-Founder and Chief Technology Officer, as earlier outlined in an 8-K filing on February 21, 2017. These funds will be used from time to time, as Provectus Pharmaceuticals requires, for its clinical development programs and corporate operations.
Provectus Biopharmaceuticals, Inc. (PVCT), closed Thursday's trading session at $0.0258, up 35.79%, on 12,022,592 volume with 243 trades. The average volume for the last 60 days is 3,636,311 and the stock's 52-week low/high is $0.011/$0.5379.
Resort Savers, Inc. (RSSV)
Promotion Stock Secrets, AllPennyStocks, OTC Markets Group, Tip.us, Stock Commander, and Pennybuster reported earlier on Resort Savers, Inc. (RSSV), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Resort Savers, Inc. is a strategic investment and development enterprise. The Company is concentrating on identifying and acquiring high demand, revenue-generating assets. Currently, it is developing and investing in the oil and gas industry and real estate development. Resort Savers is based in Shenzhen, China. The Company’s shares trade on the OTC Bulletin Board.
Resort Savers builds its asset portfolio by way of strategic acquisitions. Additionally, it is set to enter the cardboard packaging industry through acquiring Kashi Jinju Color Printing Packaging Co. Ltd. (Kashi).
Resort Savers’ assets include Kashi and WorxAmerica. Resort Savers signed a Definitive Letter of Intent (LOI) to acquire Kashi. Kashi is headquartered in Northwest China. It is a large, industrial scale cardboard processing and packaging enterprise.
Pertaining to WorxAmerica, this business designs automated solutions for industrial, environmental and energy industries to improve efficiency and systems output. In January 2015, Resort Savers purchased a 20 percent equity stake in WorxAmerica for a $2 Million USD investment.
Resort Savers’ wholly-owned subsidiary, Xing Rui International Investment Holding Group, Ltd., via its China corporation subsidiary, Hua Xin Chang Rong (Shenzhen) Technology Service Company Limited (Hua Xin Chang), purchased a 60 percent majority interest in Shenzhen Amuli Industrial Development Co. Ltd. (Amuli). This transaction closed upon the issuance of the shares of Resort Savers’ common stock and the transfer of the shares of Amuli to Hua Xin Chang in October of 2015.
Amuli is a Kvass health beverage producer. Amuli is the brand name of the Russian drink Kvass. This is a traditional Slavic and Baltic fermented beverage typically made from black or regular rye bread.
In October 2015, Resort Savers announced that it signed a Letter of Intent (LOI) to acquire Beijing Yan Dong Hao Teng Hua Gong (Beijing Yan Dong). This is a large oil-company headquartered in China. Beijing Yan Dong owns dozens of oil tanks and stations throughout China.
Resort Savers, Inc. (RSSV), closed Thursday's trading session at $0.45, up 3.60%, on 41,500 volume with 2 trades. The average volume for the last 60 days is 32,403 and the stock's 52-week low/high is $0.20/$0.6992.
Dominovas Energy Corp. (DNRG)
The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.0008, up 14.29%, on 6,195,253 volume with 14 trades. The stock’s average daily volume over the past 60 days is 14,284,048 and its 52-week low/high is $0.0006/$0.0285.
Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.
At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.
In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.
Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer
Dominovas Energy Corp. Blog
Dominovas Energy Corp. News:
Dominovas Energy Continues Discussions with Madagascar for Energy Projects
Dominovas Energy Secures Gas Supply for South Africa
Dominovas Energy Dispatches Watkins to Meet With Gas Supplier
ORHub, Inc. (ORHB)
The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.76, up 3.40%, on 102,848 volume with 75 trades. The stock’s average daily volume over the past 60 days is 9,110 and its 52-week low/high is $0.05/$2.09.
ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.
The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.
Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.
Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.
In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.
ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.
The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.
ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.
Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer
ORHub, Inc. Blog
ORHub, Inc. News:
ORhub, Inc. (ORHB) Engages NetworkNewsWire for Corporate Communications Solutions
ORHub, Inc. (ORHB) Expands Operations at Nation's Second Largest Non-Profit Hospital System
ORHub, Inc. (ORHB) Featured in NetworkNewsWire's NetworkNewsBreaks, Top 10 Mid-day Percentage Gainers, Feb 14
GreenStone Healthcare Corp. (GRST)
The QualityStocks Daily Newsletter would like to spotlight GreenStone Healthcare Corp. (GRST). Today, GreenStone Healthcare Corp. closed trading at $0.067, off by 4.29%, on 180,301 volume with 17 trades. The stock’s average daily volume over the past 60 days is 28,772, and its 52-week low/high is $0.015/$0.08.
GreenStone Healthcare Corp. (GRST), through its subsidiaries, provides medical services in the city of Toronto and the regional municipality of Muskoka, Ontario, Canada.
Located 90 minutes north of Toronto in Muskoka, GreenStone Healthcare's Addiction and Rehabilitation Treatments segment offers out-patient counseling, coaching, intervention, psychological assessment, and other related services.
GreeneStone Muskoka employs the best principles and practices currently available in the treatment of individuals with addiction. To ensure the most comprehensive and effective treatment for its clients, GreenStone Muskoka treats underlying or co-occurring disorders in tandem with the treatment of addiction.
The 36-bed addiction treatment center offers a holistic, individualized treatment approach to recovery. These private, paid programs vary in length from 45-90 days, depending on the unique needs of each resident and their response to the treatment.
GreenStone Muskoka also provides education and counseling sessions to educate the family members of its residents with the objective of helping them better understand the disease of addiction and how they should support their loved one throughout and after their recovery efforts.
GreenStone Healthcare President Shawn Leon has more than 25 years of experience managing public and private development-stage companies for various industries, including industrial minerals, aggregates, oil and gas, mining, financial, technology, hospitality and medical. He has provided financing and capital markets oversight for a number of these ventures, many of which have involved negotiations for mergers and acquisitions. He is joined by Vice President Dr. Anita Teslak, whose 25 years of combined experience as a CEO, psychologist and leadership provides valuable insight into a successful business model. Disclaimer
GreenStone Healthcare Corp. Company Blog
GreenStone Healthcare Corp. News:
GreeneStone Buys Canadian Real Estate Assets, Sells Canadian Addiction Treatment Business, and Acquires Addiction Treatment Business in Florida
GreeneStone Signs Definitive Agreement to Acquire Seastone of Delray, a Florida Limited Liability Company
GreeneStone Signs LOI to Acquire Aurora Recovery
Monaker Group, Inc. (MKGI)
The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $2.375, off by 1.04%, on 4,816 volume with 4 trades. The stock’s average daily volume over the past 60 days is 7,422, and its 52-week low/high is $1.10/$4.35.
Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.
NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.
Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.
Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.
In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.
With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.
Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer
Monaker Group, Inc. Company Blog
Monaker Group, Inc. News:
Monaker Group Appoints Robert Post to Board of Directors
Monaker Group Appoints Simon Orange to Board of Directors Appointment Advances Monaker's Plans for NASDAQ Listing
Monaker Group Shareholder Update -- 2016 Milestones and Transactional Business
eXp World Holdings, Inc. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $3.85, off by 1.53%, on 2,681 volume with 15 trades. The stock’s average daily volume over the past 60 days is 12,799, and its 52-week low/high is $0.7094/$5.84.
eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp World Holdings, Inc. Company Blog
eXp World Holdings, Inc. News:
Super Bowl Quarterback Vince Ferragamo Joins eXp Realty
eXp World Holdings, Inc. to Host Corporate Update Webinar on February 23rd
eXp Realty Nearly Triples Agent Count in 2016
Today's Top 3
Fortune Stock Alerts
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- ChineseInvestors.com, Inc. (CIIX) to Present at the SeeThruEquity Conference in Miami on February 22, 2017
- Dominovas Energy Corp. (DNRG) Enters Formal Negotiations to Open in India and Indonesia
- eXp World Holdings, Inc. (EXPI) Super Bowl Quarterback Vince Ferragamo Joins eXp Realty
- GreenStone Healthcare Corp. (GRST) Buys Canadian Real Estate Assets, Sells Canadian Addiction Treatment Business, and Acquires Addiction Treatment Business in Florida
- Monaker Group, Inc. (MKGI) Appoints Robert Post to Board of Directors
- National Waste Management Holdings, Inc. (NWMH) Expands Market Reach in New York with Acquisition of Northeast Data Destruction and Recycling
- ORHub, Inc. (ORHB) Engages NetworkNewsWire for Corporate Communications Solutions
- Singlepoint, Inc. (SING) NetworkNewsWire Releases Exclusive Audio Interview with SinglePoint
- Stealth Technologies, Inc. (STTH) Highlights Opportunities from Attendance at Leading Real Estate, Home Staging Conference